EUS-guided stent removal in buried lumen-apposing metal stent syndrome: a case series

VideoGIE. 2019 Oct 25;5(1):37-40. doi: 10.1016/j.vgie.2019.09.002. eCollection 2020 Jan.

Abstract

Background and aims: Lumen-apposing metal stents (LAMSs) play an increasing role in transgastric and transduodenal drainage of pancreatic fluid collections and allow novel EUS-guided interventions. Alongside the main adverse events of bleeding and occlusion, LAMSs can be overgrown by mucosa, which leads to the inability to visualize the stent in endoscopy.

Methods: We describe a series of 4 cases of buried LAMSs that were removed under EUS guidance for identification of the stent followed by removal with rat-tooth forceps.

Results: The median in situ time of the LAMSs in the reported 4 cases was 53 days. All stents could no longer be visualized endoscopically when drainage of necrosis was complete. All 4 buried LAMSs could be identified by EUS and were removed successfully with forceps. In 1 case, balloon dilation of the stent tract was performed before stent removal. No adverse events were observed after the procedure.

Conclusions: Buried stent syndrome is a rare adverse event of LAMSs. Here we describe a safe and effective approach for stent identification and removal without prior mucosal dissection.

Keywords: LAMS, lumen-apposing metal stent; PFC, pancreatic fluid collection; WON, walled-off necrosis.